Jonathan I. Lieber - 01 Feb 2023 Form 4 Insider Report for Rallybio Corp (RLYB)

Role
Chief Financial Officer and Treasurer
Signature
/s/ Michael Greco, Attorney-in-Fact
Issuer symbol
RLYB
Transactions as of
01 Feb 2023
Net transactions value
$0
Form type
4
Filing time
01 Feb 2023, 17:33:59 UTC
Previous filing
05 Jan 2023
Next filing
16 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLYB Option (Right to Buy) Award $0 +240,000 $0.000000 240,000 01 Feb 2023 Common Stock 240,000 $6.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the underlying shares of Common Stock on February 1, 2024 and as to the remaining 75% of the underlying shares of Common Stock in 36 equal monthly installments thereafter.

Remarks:

Chief Financial Officer and Treasurer